Study of an eye drop for dry eye disease
Part of Eyes & vision clinical trials.
This trial tests a new eye drop called DFL24498 to see if it helps people with dry eye disease. You may qualify if your dry eye is moderate to severe and other treatments haven't worked well for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had dry eye disease for at least 6 months and currently use or need artificial tears.
- Your dry eye symptoms score on a standard questionnaire is 30 or higher.
- In at least one eye, a test shows your tear production is low (less than 10 mm in 5 minutes), your cornea has damage (grade 4 or more), and your tears break up quickly (in less than 10 seconds).
- Your vision must be reasonably good (at least 20/200 or better) in each eye.
- You must not have an active eye infection, have had eye surgery in the last 6 months, or have certain other eye conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new eye drop called RCI001 to see if it works better than a placebo for people with dry eye. You may be able to join if you have had dry eye for at least 6 months and have certain signs of dry eye during exams.
This study tests a new eye drop formula to see if it safely improves dry eye symptoms. It may be a good option if you have been diagnosed with dry eye and have limited tear production.
This study tests an eye drop called lifitegrast for people with dry eye disease. It looks at whether the drops can improve eye comfort, reduce dryness, and help eye surface health. You may be able to join if you have had dry eye symptoms and used artificial tears in the past month.
This trial tests a new eye drop (FBV_01) compared to a standard hyaluronic acid eye drop for people with moderate to severe dry eye. The goal is to see if the new drop provides better relief.
This trial tests different doses of a new eye drop (HUC1-394) to see which dose works best for people with moderate to severe dry eye disease. You may qualify if your dry eye symptoms have lasted at least 3 months and you have low tear production along with other signs of dry eye.
This study tests different doses of an investigational eye drop (BRM421) to see if it safely helps people with dry eye disease. It may be an option if you have had dry eyes for a while and are looking for a new treatment.
Hear when a new Dry Eye Disease (DED) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.